[Urothelial carcinoma of the upper and lower urinary tract-which risk factors make early detection worthwhile?]

IF 0.5 4区 医学 Q4 UROLOGY & NEPHROLOGY Urologie Pub Date : 2024-11-26 DOI:10.1007/s00120-024-02479-0
Niklas Westhoff, Constantin Rieger, Axel Heidenreich, Christian Bolenz, Maurice Stephan Michel
{"title":"[Urothelial carcinoma of the upper and lower urinary tract-which risk factors make early detection worthwhile?]","authors":"Niklas Westhoff, Constantin Rieger, Axel Heidenreich, Christian Bolenz, Maurice Stephan Michel","doi":"10.1007/s00120-024-02479-0","DOIUrl":null,"url":null,"abstract":"<p><p>Urothelial carcinoma is one of the most common malignancies both in Germany and worldwide. Due to the frequent occurrence of late-onset or nonspecific symptoms, carcinomas are often diagnosed at advanced stages. Structured early detection programs have the potential to detect urothelial carcinoma in earlier stages and to improve survival rates. Various risk factors are associated with urothelial carcinoma, most notably tobacco abuse and occupational exposure, as well as genetic disorders such as Lynch syndrome in upper urinary tract carcinoma. In clinical practice, diagnostic tools include general examinations and ultrasound imaging of the urinary tract, with microhematuria and urine cytology playing key roles. For screening purposes noninvasive urine markers have demonstrated limited evidence. Despite the lack of optimal diagnostic markers for systematic early detection in high-risk populations, it is essential to ensure that every patient presenting with hematuria undergoes appropriate and risk-adapted diagnostics.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00120-024-02479-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Urothelial carcinoma is one of the most common malignancies both in Germany and worldwide. Due to the frequent occurrence of late-onset or nonspecific symptoms, carcinomas are often diagnosed at advanced stages. Structured early detection programs have the potential to detect urothelial carcinoma in earlier stages and to improve survival rates. Various risk factors are associated with urothelial carcinoma, most notably tobacco abuse and occupational exposure, as well as genetic disorders such as Lynch syndrome in upper urinary tract carcinoma. In clinical practice, diagnostic tools include general examinations and ultrasound imaging of the urinary tract, with microhematuria and urine cytology playing key roles. For screening purposes noninvasive urine markers have demonstrated limited evidence. Despite the lack of optimal diagnostic markers for systematic early detection in high-risk populations, it is essential to ensure that every patient presenting with hematuria undergoes appropriate and risk-adapted diagnostics.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[上尿路和下尿路尿路上皮癌--哪些风险因素值得早期发现?]
尿路上皮癌是德国乃至全世界最常见的恶性肿瘤之一。由于经常出现起病较晚或无特异性症状的情况,癌症往往在晚期才被诊断出来。有组织的早期检测计划有可能在早期发现尿路癌,并提高存活率。尿路上皮癌与多种风险因素有关,其中最主要的是烟草滥用和职业暴露,以及遗传性疾病,如上尿路癌中的林奇综合征。在临床实践中,诊断工具包括一般检查和泌尿道超声波成像,微量血尿和尿液细胞学起着关键作用。用于筛查的非侵入性尿液标记物证据有限。尽管缺乏对高危人群进行系统性早期检测的最佳诊断标志物,但仍有必要确保每一位出现血尿的患者都能接受适当的风险适应性诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Urologie
Urologie UROLOGY & NEPHROLOGY-
CiteScore
1.00
自引率
0.00%
发文量
0
期刊最新文献
[Non-clear cell renal cell carcinoma]. [Urothelial carcinoma of the upper and lower urinary tract-which risk factors make early detection worthwhile?] Erratum zu: Kryokonservierung von Keimzellen aus Ejakulat oder Hodengewebe zur Fertilitätsprotektion. [Antibiotic prescribing practice in urological departments in Germany: results of a cross-sectional study]. [Adjuvant therapy for renal cell carcinoma : Relevant patient and tumor factors].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1